Sexually Transmitted Diseases
Resources
Basic InformationMore InformationLatest News
HIV Virus May Hide in BrainHIV in Blood Different Than in Semen, Scientists SayAdding Third Drug May Improve Hepatitis C TreatmentIAC: Highly Active Antiretroviral Therapy Halves New HIV CasesNew Guidelines Urge Earlier Therapy for HIV PatientsNew Methods May Help Predict Survival of African HIV PatientsBenefits Seen With Early Antiretroviral Therapy in HIVStudy Suggests Link Between HPV, Skin CancerDrugs Like Viagra Linked to Higher Rates of STDsScientists Make Immune Cells in Mice That Fight Off HIVRapid Test to Detect Hepatitis C ApprovedNewly Approved HIV Test Can Spot Infection EarlierAntiretrovirals During Breast-Feeding Shield Babies From HIV, Study ShowsOld Drugs May Have New Use Against Hepatitis CMost People With HIV Begin Care Too LateAnti-HIV Drugs May Help Prevent Spread of VirusScientists Unravel Secret of HIV ResistanceIn Early Test, New Hepatitis C Drug Shows PromiseMorphine May Protect Brains of People With HIVStudy Questions Effectiveness of Single Chlamydia TestMore Clues Emerge on How HIV Infects WomenNew Drug Shows Promise for Curing Hepatitis CScientists Find Clues to How the Body Fights Off HIVWomen Would Welcome At-Home Test for STDsHerpes Infects One in Six in U.S.HIV Hides Out in Bone Marrow CellsResistance Likely to Develop With New Hepatitis C DrugsGene Therapy Shows Promise Against HIVTreating Herpes May Slow HIV in Co-Infected PatientsScientists Discover How HIV Is Transmitted Between MenFDA Revises Label for the HIV Drug DidanosinePremature Aging of the Brain Seen in HIV PatientsDrug Combo Blocks HIV Infection in MiceNew Treatment Eyed for Hepatitis CEvolving Strains of HIV May Cause Wave of Drug ResistanceHIV Infection May Increase Fracture Risk in WomenMolecule Could Help Block Sexual Transmission of HIVScientists Spot Source of Hurdle to AIDS VaccineHPV Vaccine Can Maintain Effectiveness Beyond Six YearsNew Hepatitis C Treatment Shows PromiseTenofovir DF-Emtricitabine Is Effective Initial HIV TherapyOne in Four Teen Girls Have STDsGenetic Variant Slows AIDS ProgressionGenital Herpes May Never Go DormantTeen Girls at Higher Risk for STDs: ReportSperm May Play Role in Transmission of HIVHPV Vaccine No More Painful Than Other ShotsCDC Panel Says No to Routine Use of Gardasil for BoysCost, Efficacy of HPV Vaccine in Older Women ExploredHIV Vaccine Regimen Shows Modest Benefits
Questions and AnswersLinksBook Reviews
Related Topics

Homosexuality & Bisexuality

Most People With HIV Begin Care Too Late

HealthDay News
by -- Alan Mozes
Updated: Jun 4th 2010

 

new article illustration

FRIDAY, June 4 (HealthDay News) -- Americans and Canadians infected with HIV are not getting diagnosed quickly enough after exposure, resulting in a potentially harmful delay in lifesaving treatment, a new large study suggests.

The observation stems from an analysis involving nearly 45,000 HIV-positive patients in both countries, which focused on a key yardstick for immune system strength -- CD4 cell counts -- at the time each patient first began treatment.

CD4 counts measure the number of "helper" T-cells that are HIV's preferred target.

Reviewing the participants' medical records between 1997 and 2007, the team found that throughout the 10-year study period, the average CD4 count at the time of first treatment was below the recommended level that scientists have long identified as the ideal starting point for medical care.

"The public health implications of our findings are clear," study author Dr. Richard Moore, from the Johns Hopkins University School of Medicine in Baltimore, said in a news release. "Delayed diagnosis reduces survival, and individuals enter into HIV care with lower CD4 counts than the guidelines for [initiating] antiretroviral therapy." A delay in getting treatment not only increases the chance that the disease will progress, but boosts the risk of transmission, he added.

Despite the fact that the average CD4 count at time of first presentation to care had risen over the course of the decade from 256 to 317, the researchers noted that even the high point was still below the treatment threshold of 350. Moore and his team also found that the average age at which patients had first sought care for HIV had risen over the ten-year period, from 40 to 43.

Writing in an editorial that accompanied the study, Dr. Cynthia Gay of the University of North Carolina at Chapel Hill expressed concern over the findings.

"These findings reveal that despite such compelling data, there is much room for improving our ability to link more HIV-infected individuals with effective treatment prior to immunological deterioration," she said in a news release.

Moore and his colleagues report their findings in the June 1 issue of Clinical Infectious Diseases.

More information

For more on HIV diagnosis, treatment, and CD4 counts visit the N.Y. State Department of Health.